AstraZeneca resumes AZD1222 Covid-19 vaccine trials after safety review
AstraZeneca has announced the resumption of its clinical trials for the AZD1222 Covid-19 vaccine candidate in multiple countries, following confirmation from regulators in the US, ... Read More
AstraZeneca finalizes AZD1222 Covid-19 vaccine candidate deal with EC
AstraZeneca said that it has finalized a deal with the European Commission (EC) for the delivery of up to 400 million doses of the AZD1222 ... Read More
Dexamethasone improves survival of COVID-19 patients in RECOVERY trial
The University of Oxford said that steroid dexamethasone has succeeded in reducing death in the ongoing RECOVERY trial in hospitalized patients with severe respiratory complications ... Read More
Catalent wins contract to manufacture AZD1222 COVID-19 vaccine candidate
US-based Catalent said that its subsidiary Catalent Biologics has bagged a contract to provide vial filling and packaging capacity to AstraZeneca at its manufacturing facility ... Read More
Oxford University ChAdOx1 nCoV-19 vaccine trial begins in humans
Researchers at the University of Oxford in the UK have commenced the ChAdOx1 nCoV-19 vaccine trial in healthy human volunteers to test the vaccine candidate's ... Read More
RECOVERY coronavirus trial : First patients enrolled in COVID-19 clinical trial by University of Oxford
RECOVERY coronavirus trial : University of Oxford researchers in the UK have initiated a coronavirus clinical trial called the Randomised Evaluation of COVid-19 thERapY (RECOVERY) ... Read More